Alicia K. Morgans, Matthew R. Smith, A. James O'Malley and Nancy L. Keating Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy Cancer 119
Article first published online: 12 OCT 2012 | DOI: 10.1002/cncr.27830
The current analysis of Surveillance, Epidemiology, and End Results/Medicare data suggests that few prostate cancer survivors who receive long-term androgen-deprivation therapy (ADT) undergo bone density testing; and several key populations, including African Americans and older men, have considerably lower rates of bone density screening.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field